Our results differ from that observed in carcinoma cell lines, where RARB has been identified as a tumor suppressor and induction of RARB expression, either through transfection [57–59] or treatment with pharmacological agents [30, 60, 61] promotes growth inhibition. Here, RARB is linked to neoplasm.